Which of the following is not a cholinesterase inhibitor?

Enhance your preparation for the PMHNP Certification Exam with Georgette's resources. Delve into multiple-choice questions and detailed explanations to ensure you're ready for success. Boost your study efficiency and exam confidence today!

Multiple Choice

Which of the following is not a cholinesterase inhibitor?

Explanation:
Cholinesterase inhibitors work by preventing the breakdown of acetylcholine, boosting cholinergic signaling to help with cognitive symptoms in Alzheimer's disease. Donepezil, rivastigmine, and galantamine all fit this mechanism: donepezil selectively inhibits acetylcholinesterase, rivastigmine inhibits both acetylcholinesterase and butyrylcholinesterase, and galantamine inhibits acetylcholinesterase while also modulating nicotinic receptors to enhance cholinergic transmission. Memantine does not share this mechanism; it is an NMDA receptor antagonist that reduces glutamatergic excitotoxicity and is typically used in moderate to severe disease, often in combination with a cholinesterase inhibitor. Therefore memantine is not a cholinesterase inhibitor.

Cholinesterase inhibitors work by preventing the breakdown of acetylcholine, boosting cholinergic signaling to help with cognitive symptoms in Alzheimer's disease. Donepezil, rivastigmine, and galantamine all fit this mechanism: donepezil selectively inhibits acetylcholinesterase, rivastigmine inhibits both acetylcholinesterase and butyrylcholinesterase, and galantamine inhibits acetylcholinesterase while also modulating nicotinic receptors to enhance cholinergic transmission. Memantine does not share this mechanism; it is an NMDA receptor antagonist that reduces glutamatergic excitotoxicity and is typically used in moderate to severe disease, often in combination with a cholinesterase inhibitor. Therefore memantine is not a cholinesterase inhibitor.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy